Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Affenid XL 36mg tablets
0404000M0BMACAN
|
Affenid | Methylphenidate hydrochloride | Central Nervous System | 1,107 |
|
Affenid XL 54mg tablets
0404000M0BMADAR
|
Affenid | Methylphenidate hydrochloride | Central Nervous System | 836 |
|
Affenid XL 18mg tablets
0404000M0BMAAAM
|
Affenid | Methylphenidate hydrochloride | Central Nervous System | 741 |
|
Affenid XL 27mg tablets
0404000M0BMABAT
|
Affenid | Methylphenidate hydrochloride | Central Nervous System | 734 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.